Delcath Systems Inc DCTH
News
Delcath Systems to Host Third Quarter 2026 Earnings Call
Delcath Systems Highlights Clinical Program Presentations at ESMO Congress 2026 and Independent Data on Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Delcath Systems to Participate in Upcoming Investor Conferences
Delcath Systems Reports Second Quarter 2026 Results and Business Highlights